G-protein-independent modulation of P-type calcium channels by μ-opioids in Purkinje neurons of rat
Section snippets
Acknowledgements
This work was supported by INTAS grant 05-1000008-7843 and NIH grant 1R03TW008228-01A1.
References (20)
- et al.
Signaling at zero G: G-protein-independent functions for 7-TM receptors
Trends Biochem.
(2001) - et al.
Localized secretion of ATP and opioids revealed through single Ca2+ channel modulation in bovine chromaffin cells
Neuron
(1998) - et al.
Regulation by protein kinase-C of putative P-type Ca2+ channels expressed in Xenopus oocytes from cerebellar mRNA
FEBS Lett.
(1993) - et al.
κ-Opioid receptor interacts with Na+/H+-exchanger regulatory factor-1/Ezrin-radixin-moesin-binding phosphoprotein-50 (NHERF-1/EBP50) to stimulate Na+/H+ exchange independent of Gi/G0 proteins
J. Biol. Chem.
(2004) - et al.
κ-Opioid agonist U50488 inhibits P-type Ca2+ channels by two mechanisms
Brain Res.
(1995) - et al.
Opioids potentiate transmitter release from SK-N-SH human neuroblastoma cells by modulating N-type calcium channels
Brain Res.
(1997) - et al.
Potentiation of transmitter release from NMB human neuroblastoma cells by κ-opioids is mediated by N-type voltage-dependent calcium channels
Brain Res.
(1999) - et al.
Direct interaction and functional coupling between metabotropic glutamate receptor subtype 1 and voltage-sensitive CaV2.1 Ca2+ channel
J. Biol. Chem.
(2003) - et al.
Molecular biology of the opioid receptors: structures, functions and distributions
Neurosci. Res.
(1995) - et al.
GABAB receptor inhibition of P-type Ca2+ channels in central neurons
Neuron
(1993)
Cited by (17)
Addiction and the cerebellum with a focus on actions of opioid receptors
2021, Neuroscience and Biobehavioral ReviewsCitation Excerpt :Endomorphin-1 exhibited opioid and non-opioid-functionalities which were evaluated in physiological and pathologic conditions (Lengyel et al., 2016). A study indicated that endomorphin-1 facilitated the current of P-type calcium channels in purkinje neurons of rat cerebellum (Iegorova et al., 2010). Endomorphin-2 is produced in cells of the substantia nigra, nucleus raphe magnus, VTA, pontine nuclei and the amygdala, and endomorphin-2-containing fibers have been observed in the ventral cerebellum which could source from these nuclei (Pierce and Wessendorf, 2000).
Replacement of current opioid drugs focusing on MOR-related strategies
2020, Pharmacology and TherapeuticsCitation Excerpt :Repeated in vivo treatment with morphine induced an increase in Cav1.2 protein level in the mouse frontal cortex and limbic forebrain, and morphine-induced place preference was suppressed by an L-type VDCC antagonist (Shibasaki, Kurokawa, Mizuno, & Ohkuma, 2011). While Cav2.1 channels play limited roles in afferent pain pathways (Bourinet et al., 2014), and opioid receptor effects are generally presumed to be inhibitory, activation of Cav2.1 is a common mechanism described for both MORs and DORs in several supraspinal structures (Iegorova, Fisyunov, & Krishtal, 2010; Margolis, Fujita, Devi, & Fields, 2017) whose pharmacological consequences need to be clarified. Cav2.2 channels are almost exclusively expressed in neuronal tissue (Nowycky, Fox, & Tsien, 1985).
Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor
2017, NeuropharmacologyCitation Excerpt :We previously demonstrated that MOR activation in some VTA neurons, including dopamine neurons, is excitatory, an effect that requires Cav2.1 and G protein activity in the recorded neuron, and is independent of synaptic input (Margolis et al., 2014). MOR induced activation of Cav2.1 has also been reported in the cerebellum (Iegorova et al., 2010), and somatodendritic Cav2.1 expression (Ishibashi et al., 1995) and currents (Philippart et al., 2016) have been reported in substantia nigra and VTA neurons. Together, these data indicate that activation of Cav2.1 is a common mechanism for both MORs and DORs in VTA neurons.
Opioid Modulation of Voltage-Gated Calcium Currents
2016, Neuropathology of Drug Addictions and Substance Misuse Volume 3: General Processes and Mechanisms, Prescription Medications, Caffeine and Areca, Polydrug Misuse, Emerging Addictions and Non-Drug AddictionsFunctions of the chemokine receptor CXCR4 in the central nervous system and its regulation by μ-Opioid receptors
2014, International Review of NeurobiologyCitation Excerpt :Endogenous opioids have very diverse roles in many different tissues. For example, opioids typically have an inhibitory effect on neuronal activity, but the μ-opioid receptor agonist DAMGO (Tyr-d-Ala-Gly-N-methyl-Phe-Gly-ol) is able to regulate resting membrane potential in Purkinje neurons by its ability to increase intracellular calcium levels via a G protein-independent pathway, which results in increased neurotransmitter release (Iegorova, Fisyunov, & Krishtal, 2010). Painful stimuli including injuries and lipopolysaccharide administration are known to cause an upregulation of the μ-opioid receptor agonist β endorphin, which serves as a natural form of analgesia (Molina, 2002), and opioids are able to control feeding depending on which receptor subtype is bound (Gosnell & Levine, 2009).
Endogenous opiates and behavior: 2010
2011, PeptidesCitation Excerpt :Naloxone reversed the inhibitory response properties of nucleus reticularis lateralis neurons after electroacupuncture stimulation in rats [453]. G-protein-independent modulation of P-type Ca(2+) channels was observed with DAMGO-induced facilitation of Purkinje neurons in rats [288]. DAMGO suppressed rat hypoglossal motoneuron inspiratory activity that was reversed by ampakine therapy [393].